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Abstract
A pharmacophore consists of the parts of the structure of the ligand that are sufficient to
express the biological and pharmacological effects of the ligand. It is usually a substructure of
the entire structure of the ligand. Small organic molecules called ligands or metabolites in the
cell form complexes with biomolecules (usually proteins) to serve different purposes. The
sites at which
the ligands bind are known as ligand binding sites, which are essentially “pockets”
which have complementary shapes and patterns of charge distribution with the ligands.
Sometimes a pocket is induced by the ligand itself. If we study different bound conformations of
ligands it is found that they share a specific 3 dimensional pattern that is more or less common
and is responsible for its binding and which is complimentary in 3 dimensional geometry and
charge distribution pattern with its cognate binding site in the protein.
This work studies the three dimensional structure of the consensus ligand binding site for the
ligand FMN. A training set for the ligand binding sites was made and
a 3D consensus binding site motif was determined for FMN. The FMN system was studied
and its binding sites in its respective regulator proteins. The ability to identify ligand binding
site by scanning the 3D binding site consensus motif in protein 3D structures is an important
step in drug target discovery. Once a pharmacophore template is found it can also be used to
design other potential molecules that can bind to it and thus serve as novel drugs.
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INTRODUCTION
The pharmacophore for a given ligand includes the parts of the structure of the ligand that
are sufficient to express the biological and pharmacological effects of the ligand. Usually only a
substructure of the whole structure of the ligand molecule is responsible for the biological effects
of a ligand. When a ligand binds to a protein molecule it binds to a specific 3 dimensional
conformation of the ligand binding site in the protein which is known to be conserved for each
and every ligand[8].The ligand binding site essentially serves as a pocket that has a
complementary shape and charge distribuition with the ligand. When a protein molecule is
unfolded the sites responsible for the ligand binding can be present in different parts of the
protein molecule. However on protein folding the sites form the specific 3 dimensional pocket
that is complementary in shape and charge distribution to the ligand molecule that is binding to
the protein and forms the ligand binding site for that particular ligand. (Fig. 1)
Figure 1: Preservation of Ligand binding site 3-D Geometry. The figure shows a protein that has different secondary
structures. Unfolded they have the four sites responsible for binding the ligand namely R1, R2, R3 and R4 in different
sections of the protein. However on folding they form the tetrahedral model as shown in the figure [11].
Several research groups, including N Schormann et al. [17] have focused on a structure based
approach to identify pharmacophores of a particular ligand. Studying the 3 dimensional structure
of the ligand binding site of receptor protein molecules for a particular ligand can lead to
pharmacophore identification for
a particular ligand. Pharmacophore identification can subsequently lead to the discovery
of novel molecules that can mimic the ligand and lead to drug discovery. For example a
simple illustration of binding site will be [3]:
Figure 2:Ligand Binding Site[4]
There are obvious sites for hydrogen bonds and van der Waal’s interactions and it can be
postulated that a molecule that could bind to this site would provide functional groups that
could hydrogen bond to the receptor functional groups. The ligand molecule and its
corresponding binding site in the protein must be complementary in both 3D geometry
(architecture) and charge distribution pattern.
Figure 3:Ligands binding to the ligand binding site[4]
From identification of the ligand binding sites (the blue structure), novel molecules can be
designed that have functional groups that are complimentary to the binding site residue like:
Figure 4: Pharmacophore[4]
Keeping this in mind different molecules that can bind to the particular pharmacophore
can be searched for. The search may give molecules like:
Figure 5:Possible molecules binding to the ligand binding site[4]
For our research we seek to identify the specific 3 dimensional structure responsible for the
binding of the ligand FMN by studying proteins that have FMN bound to them. The DCRR or
double centroid reduced representation [11] is used to study the protein structures to identify a
common 3 dimensional motif. The reason DCRR was used is because the default AAR or all
atom representation gives too much information and makes it very difficult and complicated
to correctly identify a 3D motif. DCRR on the other hand minimizes the information
presented while retaining the amount of information needed to identify the conserved 3
dimensional motif.
It was found by Dr. Vicente Reyes and Vrunda Seth in their research [11] that for small
ligands like GTP, ATP and FMN the 3 dimensional motif in the ligand binding site can be
accurately represented as a tetrahedral structure with the four most dominant amino acids in
the side chain or backbone interacting with the ligand, making up the four edges of the
tetrahedron. If the 3 dimensional motif was represented as a triangular structure it could not
accurately capture a lot of information and led to a lot of false positives while screening for
ligand binding sites. However anything more than a tetrahedral model was just unnecessarily
complicating the 3 dimensional motif identification process while giving the
same results as when a tetrahedral structure was used. Thus for identifying the fixed 3
dimensional ligand binding site responsible for binding FMN we study some structures
that have FMN bound to it and try and construct a tetrahedral motif that is common to all
the proteins. The proteins that are studied that are known to have FMN bound to it make
up what is known as the training set. Fig.6 illustrates few protein structures that contain a
bound ligand and identify the fixed 3 dimensional motif responsible for ligand binding by
representing it as a tetrahedron.
Figure 6: Training set for finding pharmacophores [4]
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For example based on the four training structures on the previous page, the consensus binding
site for the ligand constructed in Fig. 7:
Figure 7: Mathematical model for the ligand binding site [4]
Once the fixed 3 dimensional motif was found by studying the training structures an
algorithm written in FORTRAN was utilized to identify if that 3 dimensional motif was
present in protein structures passed into the algorithm. The algorithm was first trained and
tested on training structures having known ligand interactions and then subsequently used on
unannotated structures in PDB with unknown function to identify possible candidates that
might have FMN bound to them.
_+
+_
_
Given below is a description of FMN. The functional groups marked in blue in
the structure are good candidates as contact points of the receptor protein
and was used to construct the consensus binding site of the pharmacophore.
1. FMN:
FMN or flavin mononucleotide functions as a prosthetic group for several
oxidoreductases. It is a stronger oxidizing agent than NAD and is derived from
riboflavin like FAD [20].
Figure 8: FMN
MOTIVATION:
Our aim is to determine the 3 dimensional consensus binding site motif which will help in the
design of novel molecules that will bind to those sites and thus serve as possible novel drugs.
Drugs can either act as agonists or antagonists for the particular binding site.
Agonists are chemicals that bind to the receptor and trigger a response by the cell.
Sometimes the agonist can trigger a response that is more than the original ligand
would have produced. These agonists are called as super- agonists. At other times the
agonist may do the opposite and trigger a lower response. These agonists are called
inverse-agonists. A receptor antagonist is basically an inhibitor that binds to the
receptor site thus preventing the ligand from binding to it and triggering a response.
Though pharmacophore studies have been conducted before, most of them are based on the
all atom representation for proteins. In our study however this work uses the double centroid
reduced representation [2]. Using the DCRR representation makes the analysis of the 3
dimensional structures easier because of the display presented by DCRR. The AAR model
display can be overwhelming and that makes it difficult to model a motif from it. However
DCRR captures just enough chemical information to accurately display the secondary
structure of a protein.
Figure 9: Finding pharmacophores in DCRR as opposed to AAR. The DCRR reduces the information
presented as shown in the figure and makes it easier to construct a 3 dimensional motif of the
ligand binding sites [11].
SPECIFICAIMS:
Specific Aim #1. Using a Training Set of a dozen solved structures with bound FMN, Determine and
Analyze the Characteristics of the Binding Site for FMN and build a 3D Binding Site tetrahedral
Consensus Motif for use in Screening.
Specific Aim #2. Screen  a Dataset Composed of Most of the Current Functionally Unannotated
Structures from the PDB for Screening using the screening procedure established for the above
mathematical model for the binding site.[11]
METHODSAND RESULTS:
The whole process can be subdivided into three broad categories
a) Gather data that can be used to prepare the screening algorithm
b) Train the screening algorithm by testing it on a predefined training set
c) Use the algorithm to screen functionally unannotated structures in PDB
Gather data to prepare the screening algorithm
The following flowchart elucidates the steps that were used to gather this data
Figure 10: Flow of the whole process: The proteins to be used as the training structures are first identified and
converted to DCRR. After that the Van der Waals and Hydrogen bonding information is obtained by running
FORTRAN programs that determine this information. From this the most dominant atoms and interactions are
identified and used as qualitative and quantitative inputs for the screening algorithm. Once this screening
algorithm is ready it is trained by testing it on structures known to have FMN bound to them. The last step of the
process is to use the screening algorithm to screen unannotated structures in PDB
Identifying proteins from PDB that have FMN as a ligand bound to it:
The PDB database was searched to find sixteen proteins that actually have FMN bound to
it. These proteins were used to study the structures of the proteins and then determine the
tetrahedral motif that was highlighted as being common to these proteins. The following
proteins were selected
Table 1: Training set
FMN
PDB ID MOLECULE NAME
1D3G DIHYDROOROTATE DEHYDROGENASE
1B1C PROTEIN (NADPH-CYTOCHROME P450
REDUCTASE)
1NRG pyridoxine 5'-phosphate oxidase
2BXV DIHYDROOROTATE DEHYDROGENASE
2RDU Hydroxyacid oxidase 1
2RDW Hydroxyacid oxidase 1
2PRH Dihydroorotate dehydrogenase, mitochondria
2RDT Hydroxyacid oxidase 1
3HR4 Nitric oxide synthase, inducible
3KVJ Dihydroorotate dehydrogenase, mitochondria
2NZL Hydroxyacid oxidase 1
2FPY Dihydroorotate dehydrogenase, mitochondrial
precursor
1QZU hypothetical protein MDS018
3KVK Dihydroorotate dehydrogenase, mitochondrial
3KVM Dihydroorotate dehydrogenase, mitochondrial
2WKP NPH1-1, RAS-RELATED C3 BOTULINUM TOXIN
SUBSTRATE 1
All the selected proteins are proteins that are found in humans so that we can eliminate any
irregularity arising from diverse species.
Converting to DCRR
Since this work utilizes the benefits of using a DCRR structure as opposed to a AAR structure
as discussed above one of the very important steps is to convert the structures into DCRR ones
from the default AAR structure given in PDB. There can be two ways of doing this. The first
way is to use the DCRR website and give the protein name and convert it from there. The
second way is to use the programs and scripts written by Vrunda Seth and Dr. Vicente Reyes
for their work involving conversion of AAR structures into DCRR structures.
For this thesis the second approach was used this is primarily because of three reasons.
1. The DCRR website is not comprehensive. It does not have all the structures that are
present in PDB. Most of the proteins used in this work was not present in the website.
2. A lot of additional files generated by the DCRR conversion program were used in this
work. This is primarily related to the Van der Waals and hydrogen bonding
information in the proteins. These text files are not available in the website.
3. Getting the information from a Unix shell and a fast processor was faster than
relying on the internet.
Get Van der waals and Hydrogen bonding information from the DCRR structures
Running the DCRR algorithm in the above steps gave the Van der Waals and hydrogen
bonding information in separate files. These files were combined to get the ligand
interactions for each and every protein. Basically to find out the Hydrogen bonding
information a nearest neighbor analysis was used to identify H-bonding and VDW
interactions. A sphere typically of radius 5.0 - 6.0 Å was constructed around every atom in
the protein as center; all other atoms found in the interior of such a sphere is considered
‘neighbors’ of the central atom. Hydrogen bonds were taken to be those that are within close
neighborhood of 2.80 Å between central atom and neighbor, with the compatible chemical
identities (those involving P, O, N and/or S). As for van der Waals interaction, we considered
only those of the C-H• • • • H-C type and whose distances between the carbon atoms are
within close neighborhood of 3.38 Å[11][21]
After this was done the distance of the ligand molecule to the amino acid backbone or side chain
was calculated using the distance formula 20
22
0 )()()( 0 zzyyxx  applied to the
Cartesian coordinates of the amino acid in the protein and the ligand molecule. See Fig. 11
Tabulate the results and identify the most dominant binding sites
Once the ligand interactions were extracted from the different proteins a spreadsheet
was made to carefully study the proteins and identify a tetrahedral model to be used for
screening
Figure 11: Spreadsheet for analyzing the ligand binding site in the training structures (See attached spreadsheet
Analysis.xls for the full spreadsheet) : This spreadsheet lists the amino acids side chains or backbones that
interacted with the different sites in the ligand. The distance in Angstroms between the sites and the protein
were also tabulated so that they could be studied. From this spreadsheet the most dominant sites of the ligand that
interacted with the protein were identified. This was done by observing the interactions for the different proteins
having FMN bound to it in the spreadsheet and tabulating the interacting atoms that were prevalent across all the
proteins
For FMN they were found to be:
1. C2
2. C6
3. O2P
4. O3P
However, when these four sites were considered a lot of false positives were identified for
proteins that had GTP/GDP bound to them (Table 3). This was due to the fact that the
phosphate group was decreasing the specificity of the algorithm. Hence the phosphate group
binding site of FMN was
not considered as one of the atoms forming the edge of the tetrahedron that were interacting
with the amino acid atoms of the sidechain or backbone of the protein. Thus the atoms of
FMN that had predominant interactions with the protein molecules were now:
1. C2
2. C6
3. C5a
4. O2
These atoms are highlighted in Fig. 12
Figure 12: Tetrahedral Motif in FMN
So the tetrahedral motif was identified to be in the isoalloxazine ring of FMN. These would
serve as the 4 nodes of the tetrahedral motif. The screening algorithm needs one of the nodes
to be assigned as the root. This can be any of the four nodes. What this root node does is act
as a starting point from which all the intermolecular interactions are found out. Our
screening algorithm is written in Fortran77 and 90, and requires the parameters of the
3DSM, as input (i.e., the identities of the amino acid residues making up the 3D Screening
Motif, the lengths of its 6 sides, and the nature of their interaction with the ligand, i.e., via
backbone or via side chain, a total of at least
14 parameters). Candidate 3D Screening Motif ‘sides’ are sequestered by the algorithm
from the test protein structure 3D structure based on the input parameters as well as the
‘connectivity’ (i.e., whether each node is connected to the same root, as well as to each
other). In ascertaining
connectivity, groups of centroids called’ clusters’ are first selected, from which groups called
‘trees’
are further selected. An ‘error margin’, ε,, ±1.4 Å, is added to the lengths of the sides of the
3D SM              to incorporate a fuzzy element into the screening process.[11]. If we do not
give an error margin then we are making the dimensions of the tetrahedron very specific and
not accounting for any small difference of the position of the atoms making up the nodes of
the tetrahedral model. This would lead to a lot of false negatives. The error margin was
chosen as 1.4 Å, to get a good rate of specificity and sensitivity. (Table 4, 5, 6)
O2 was chosen as the root node, C2 as n1, C6 as n2 and C5a as n3.
Identifying the amino acids in the binding site that bound the ligand atom
Once the tertrahedral motif was identified it was necessary to find out what were the amino acids
that were present in the sidechain or backbone of the protein molecule that were interacting with
the ligand molecule. Again this was found by analyzing the spreadsheet that was prepared. In
many cases there was more than one amino acid that was found to be common in the proteins for
each node. The algorithm used allows for this. If there was more than one amino acid
predominant they were all taken into consideration. The table below shows the predominant
amino acids interacting with each node in the ligand.
Table 2: Predominant amino acids interaction with each node in the ligand
This represents the tetrahedral motif model for the ligand binding site in the double centroid
reduced representation.
The data gathered were sufficient to proceed with the screening step in which the algorithm would
be trained using a few test structures.
Node Amino Acids
C2 ALA(sidechain), GLN(sidechain)
C6 TYR (sidechain), THR (sidechain)
C5a THR(backbone), GLY (backbone)
O2 ASN(sidechain), LYS(sidechain)
Verifying the screening algorithm
The screening algorithm takes the tetrahedral motif that was constructed above to capture
the conserved ligand binding site consensus. The four most dominant interacting atoms
make up the four nodes of the tetrahedron. One of the nodes is arbirtraily chosen as the root
R and the others as the three nodes n1, n2 and n3. The distances between the nodes give us
the exact dimensions of the tetrahedral motif. Thus the six distances Rn1, Rn2, Rn3, n1n2,
n2n3 and n1n3 are the quantitative parameters that construct the fixed tetrahedral screening
motif (Fig. 15).
Once we have the tetrahedral motif we try and identify where the motif can be found in the
structure of the protein to be screened. If the tetrahedral motif does not exist then obviously the
protein is eliminated and is considered as a negative for the screen. So the first step is to look
for the amino acids in the sidechain or backbone that interact with the four nodes (Table 2). As
in our case there can be more than one dominant amino acid interactions for each node. The
screening algorithm allows for this. So in the first step we try to eliminate all the sites which do
not have the dominant amino acids interacting with the four nodes (Fig. 16). Now these amino
acids can be coming from the sidechain or backbone of the protein.  Since they can come from
either one for each amino acid we further eliminate some sites because they are not coming
from the backbone of the protein or maybe the sidechain of the protein (Fig 17).
Now that the possible sites have been found in a qualitative manner we have actually identified
the clusters in the protein structure which may have the tetrahedral motif we constructed from
the training structures. However we do not really want all the clusters. The tetrahedral motif is
now considered quantitatively to see if the six quantitative parameters discussed above match.
Of course we do not consider the nodes and the roots as fixed dimensionless points. Variations
occur among proteins and if we just had a tetrahedral of one fixed size then we will not get any
positives. To account for this we create a small sphere of +- 1.4 angstroms around the root and
the three nodes (fuzzy factor). We account for all lengths that satisfy this. We calculate all the
distances among the amino acids and construct the trees from these clusters having the
allowable distances (Fig 18).
The last step would be to match these edge nodes distances to the set of allowable distances
we found above and see if the tetrahedral motif exists in the protein (Fig 19, 20).
Fortran programs achieve all of the above steps. If there is no match found then the program
generates a blank output for that step.
Figure 13: Creating an irregular tetrahedral motif to be used for screening [11]
Figure 14: Screening algorithm [11]
Figure 15: Screening Algorithm Preparation [11]: The entire protein structure of the protein to be tested in DCRR
and the identified tetrahedral motif is taken.
Figure 16: Screening Algorithm Step1 [11] : Only the amino acids that were identified in the tetrahedral motif are
considered in the structure of the protein to be tested
Figure 17: Screening Algorth Step 2 [11]: The backbones and side chain centroids of the test protein are identified
Figure 18: Screening Algorithm Step3 [11]: The distances between the interacting atoms are calculated and only
those within the limits of the tetrahedral model are selected
Figure 19: Screening Algorithm Step 4 [11]: The roots and the nodes are chosen from the protein structures
Figure 20: Screening Algorthm Step 5 [11]: The node-edges that have lengths that are within limits of the 3D
search motif are selected
Figure 21: Screening algorithm flow: This flowchart describes the steps in the screening algorithm only. The
different steps that the algorithm follows to screen a protein is described.
Get a few structures
The Sixteen training structures were used to train the algorithm. The parameters derived
from the training structures were fed into the algorithm. These parameters are used to create
the tetrahedral motif. These include the qualitative parameters i.e. the ligand atoms that form
the four nodes of the tetrahedral (the root and the three nodes) and also the quantitative
parameters that set the dimensions of the tetrahedral motif.
Once the algorithm is trained it was tested against structures with known ligand binding sites
to test for true positives, true negatives, false positives and false negatives. (Table 3, 4, 5, 6)
Convert them into DCRR
These structures were then converted to DCRR structures from AAR structures using
Vrunda Seth’s algorithm.
Prepare nodes_file
Once the DCRR structures for the proteins were ready a simple grep was performed to get
only those amino acids which were identified in the pre-screening steps above. These files
made up the input nodes files for the next steps.
Find out the distance between each node
The distance between each node was found using the fortran program nrst_nghbr.f. The
distances were separated into different files for the distances Rn1, Rn2, Rn3, n1n2, n2n3,
n1n3.
Find lengths that satisfy allowable node lengths
Using the median length found in the previous step for each group the lengths that satisfy
allowable node lengths was computed using the six fortran programs dist_e1e2.f,
dist_e1e3.f, dist_e2e3.f, dist_Re1.f, dist_Re2.f, dist_Re3.f. The allowable node lengths
account for the fuzzy factor as described above
Output gathered into one file, tagged merged together and sorted
The outputs from the above programs were first gathered into one file for each node
length if there were multiple outputs. Then the files were tagged to indicate what node
length the output was from (Rn1, Rn2, Rn1, n1n2, n2n3 or n1n2) and merged together
into one file. This file was then sorted to do a group by all the node lengths.
Find clusters
Using the output file from the previous step the clusters were found using the
fortran program find_clstrs_3_nodes.f90.
Find trees
Using the output of the clusters file above the trees were generated using the
fortran program find_trees_3_nodes.f90
Find the edges
Once the output above was generated all the branches (Rn1, Rn2, Rn3) were gathered
together using a simple grep. Then the find_edgenode.f fortran program was used to find
the edges (n1n2, n1n3, n2n3). These edges were matched with the branches to create the
tetrahedral in the protein molecule. Thus the tetrahedral motif was confirmed for FMN.
FAD bound
protein
Tested
Positive?
FMN bound
protein
Tested
Positive?
GDP/GTP
bound protein
Tested
Positive?
3MBG No 1D3G Yes 3BRW No
3QJ4 No 1B1C Yes 1MH1 No
2CFY No 1NRG Yes 1JAH No
2QTL No 2BXV Yes 1JAI No
3QFS No 2RDU Yes 3ZYS No
3QFT No 2RDW Yes 3KUC No
2VZ2 Yes 2PRH Yes 1GNP No
2QTZ Yes 2RDT Yes 1GNQ No
3O55 No 3HR4 Yes 1GNR No
2UXX No 3KVJ Yes 1KAO No
2BK3 No 2NZL Yes 3CF6 No
3NKS No 2FPY Yes 3KUB No
3AHQ No 1QZU Yes 1FB1 Yes
3AHR No 3KVK Yes 3NC1 No
3QFC No 3KVM Yes 3NBY No
3QE2 No 2WKP Yes 3NBZ No
3QFB No 1HE4 Yes 3NCO No
3QFA No 2WV8 Yes 3Q7Q No
2WBI No 3QFC Yes 3Q72 No
2BYB No 3QE2 Yes 3Q7P No
3QFR No 3QFR Yes 1FBX No
2VRM No 3G0U Yes 2Q3F No
2VRL No 1D3H Yes 2CLS No
1QR2 No 3F1Q Yes 2J1L No
1GOS No 3FJ6 Yes 2EKI No
2CKJ No 3FJL Yes 2OCB No
2BXR Yes 3G0X Yes 3GFT No
2BXS Yes 2PRL Yes 2G6B No
3NHF No 2PRM Yes 3LLU No
3NHJ No 2W0U Yes 1KHE No
3NHK No 2Q9U Yes 1KHB No
3NHL No 2BOM Yes 1GUA No
3NHP No 1P4M Yes 2GMV No
3NHR No 3HY8 Yes 1WQ1 No
3NHS No 3KVL Yes 1TBG No
3NHU No 3FJO Yes 1AM4 No
3NHW No 3U2O Yes 2BC9 No
3NHY No 1Q9S Yes 1ZW6 No
3ZYX No 2WKQ Yes 2A5D No
1UMK Yes 2WKR Yes 2EW1 No
2H94 No 2FPT Yes 1A2B Yes
2VIG No 2FPV Yes 2FG5 No
2JIF No 2FPY Yes 3T5G Yes
2J3N No 2FQI Yes 1LF0 No
3PO7 No 1M51 No
1ZX1 No 1NHX No
1OJA No 1XTS No
2AAQ No 3EA5 Yes
2UXW No 1KHF No
3DJG No 1KHG No
3DK4 No 1QRA No
3DK9 No 3RAP No
2QR2 No 2GIL No
2F5Z No 2RAP No
2IW5 No 2B8W No
3DK8 No 2B92 No
3DJJ No 2D4H No
2Z5X No 2G3Y No
2Z5Y No 3CBQ No
3GOU No 1RRP No
3F1Q No 1DOA No
3FJ6 No 3P32 Yes
3FJL No 1K5D No
3G0X No 1K5G No
3LF5 No 3TW4 Yes
3H8Q No 2J5X No
3DU8 No 2DPX No
1T9G Yes 2GJS No
1S1Q No 1X3S No
2ZZC No 2GAO No
2ZZO No 2HT6 No
2ZZB No 1RA7 No
1SIR No 2OHF No
1OJD No 3T5I No
1OJ9 No 2A5F No
Table 3:  When the algorithm was tested with the nodes as C2, C6, O2P and O3P the algorithm incorrectly
identified a lot of structures having GTP/GDP bound to it as a false positive.
FAD bound
protein
Tested
Positive?
FMN bound
protein
Tested
Positive?
GDP/GTP
bound protein
Tested
Positive?
3MBG No 1D3G Yes 3BRW No
3QJ4 No 1B1C Yes 1MH1 No
2CFY No 1NRG Yes 1JAH No
2QTL No 2BXV Yes 1JAI No
3QFS No 2RDU Yes 3ZYS No
3QFT No 2RDW Yes 3KUC No
2VZ2 No 2PRH Yes 1GNP No
2QTZ No 2RDT Yes 1GNQ No
3O55 No 3HR4 Yes 1GNR No
2UXX No 3KVJ Yes 1KAO No
2BK3 No 2NZL Yes 3CF6 No
3NKS No 2FPY Yes 3KUB No
3AHQ No 1QZU Yes 1FB1 No
3AHR No 3KVK Yes 3NC1 No
3QFC No 3KVM Yes 3NBY No
3QE2 No 2WKP Yes 3NBZ No
3QFB No 1HE4 Yes 3NCO No
3QFA No 2WV8 Yes 3Q7Q No
2WBI No 3QFC Yes 3Q72 No
2BYB No 3QE2 Yes 3Q7P No
3QFR No 3QFR Yes 1FBX No
2VRM No 3G0U Yes 2Q3F No
2VRL No 1D3H Yes 2CLS No
1QR2 No 3F1Q Yes 2J1L No
1GOS No 3FJ6 Yes 2EKI No
2CKJ No 3FJL Yes 2OCB No
2BXR Yes 3G0X Yes 3GFT No
2BXS Yes 2PRL Yes 2G6B No
3NHF No 2PRM Yes 3LLU No
3NHJ No 2W0U Yes 1KHE No
3NHK No 2Q9U Yes 1KHB No
3NHL No 2BOM Yes 1GUA No
3NHP No 1P4M Yes 2GMV No
3NHR No 3HY8 Yes 1WQ1 No
3NHS No 3KVL Yes 1TBG No
3NHU No 3FJO Yes 1AM4 No
3NHW No 3U2O Yes 2BC9 No
3NHY No 1Q9S Yes 1ZW6 No
3ZYX No 2WKQ Yes 2A5D No
1UMK No 2WKR Yes 2EW1 No
2H94 No 2FPT Yes 1A2B No
2VIG Yes 2FPV Yes 2FG5 No
2JIF Yes 2FPY Yes 3T5G No
2J3N Yes 2FQI Yes 1LF0 No
3PO7 No 1M51 No
1ZX1 Yes 1NHX No
1OJA Yes 1XTS No
2AAQ No 3EA5 No
2UXW No 1KHF No
3DJG No 1KHG No
3DK4 No 1QRA No
3DK9 No 3RAP No
2QR2 No 2GIL No
2F5Z No 2RAP No
2IW5 No 2B8W No
3DK8 No 2B92 No
3DJJ No 2D4H No
2Z5X No 2G3Y No
2Z5Y No 3CBQ No
3GOU No 1RRP No
3F1Q No 1DOA No
3FJ6 No 3P32 No
3FJL No 1K5D No
3G0X No 1K5G No
3LF5 No 3TW4 No
3H8Q No 2J5X No
3DU8 No 2DPX No
1T9G Yes 2GJS No
1S1Q No 1X3S No
2ZZC Yes 2GAO No
2ZZO Yes 2HT6 No
2ZZB Yes 1RA7 No
1SIR No 2OHF No
1OJD No 3T5I No
1OJ9 No 2A5F No
Table 4:  When the algorithm was tested with the nodes as C2, C6, O2 andC5a and an error margin of 1.8
angstroms a lot of structures having FAD as a ligand and not FMN was picked up. Thus the false positive rate
was high.
FAD bound
protein
Tested
Positive?
FMN bound
protein
Tested
Positive?
GDP/GTP
bound protein
Tested
Positive?
3MBG No 1D3G Yes 3BRW No
3QJ4 No 1B1C Yes 1MH1 No
2CFY No 1NRG Yes 1JAH No
2QTL No 2BXV Yes 1JAI No
3QFS No 2RDU Yes 3ZYS No
3QFT No 2RDW Yes 3KUC No
2VZ2 No 2PRH Yes 1GNP No
2QTZ No 2RDT Yes 1GNQ No
3O55 No 3HR4 Yes 1GNR No
2UXX No 3KVJ Yes 1KAO No
2BK3 No 2NZL Yes 3CF6 No
3NKS No 2FPY Yes 3KUB No
3AHQ No 1QZU Yes 1FB1 No
3AHR No 3KVK Yes 3NC1 No
3QFC No 3KVM Yes 3NBY No
3QE2 No 2WKP Yes 3NBZ No
3QFB No 1HE4 Yes 3NCO No
3QFA No 2WV8 Yes 3Q7Q No
2WBI No 3QFC Yes 3Q72 No
2BYB No 3QE2 Yes 3Q7P No
3QFR No 3QFR Yes 1FBX No
2VRM No 3G0U Yes 2Q3F No
2VRL No 1D3H Yes 2CLS No
1QR2 No 3F1Q Yes 2J1L No
1GOS No 3FJ6 Yes 2EKI No
2CKJ No 3FJL Yes 2OCB No
2BXR Yes 3G0X Yes 3GFT No
2BXS Yes 2PRL Yes 2G6B No
3NHF No 2PRM Yes 3LLU No
3NHJ No 2W0U Yes 1KHE No
3NHK No 2Q9U Yes 1KHB No
3NHL No 2BOM Yes 1GUA No
3NHP No 1P4M Yes 2GMV No
3NHR No 3HY8 Yes 1WQ1 No
3NHS No 3KVL Yes 1TBG No
3NHU No 3FJO Yes 1AM4 No
3NHW No 3U2O Yes 2BC9 No
3NHY No 1Q9S No 1ZW6 No
3ZYX No 2WKQ Yes 2A5D No
1UMK No 2WKR Yes 2EW1 No
2H94 No 2FPT Yes 1A2B No
2VIG No 2FPV Yes 2FG5 No
2JIF No 2FPY Yes 3T5G No
2J3N No 2FQI Yes 1LF0 No
3PO7 No 1M51 No
1ZX1 No 1NHX No
1OJA No 1XTS No
2AAQ No 3EA5 No
2UXW No 1KHF No
3DJG No 1KHG No
3DK4 No 1QRA No
3DK9 No 3RAP No
2QR2 No 2GIL No
2F5Z No 2RAP No
2IW5 No 2B8W No
3DK8 No 2B92 No
3DJJ No 2D4H No
2Z5X No 2G3Y No
2Z5Y No 3CBQ No
3GOU No 1RRP No
3F1Q No 1DOA No
3FJ6 No 3P32 No
3FJL No 1K5D No
3G0X No 1K5G No
3LF5 No 3TW4 No
3H8Q No 2J5X No
3DU8 No 2DPX No
1T9G Yes 2GJS No
1S1Q No 1X3S No
2ZZC No 2GAO No
2ZZO No 2HT6 No
2ZZB No 1RA7 No
1SIR No 2OHF No
1OJD No 3T5I No
1OJ9 No 2A5F No
Table 5:  When the algorithm was tested with the nodes as C2, C6, O2 andC5a and an error margin of 1.4
angstroms the selectivity and specificity of the algorithm was optimal.
FAD bound
protein
Tested
Positive?
FMN bound
protein
Tested
Positive?
GDP/GTP
bound protein
Tested
Positive?
3MBG No 1D3G Yes 3BRW No
3QJ4 No 1B1C Yes 1MH1 No
2CFY No 1NRG Yes 1JAH No
2QTL No 2BXV Yes 1JAI No
3QFS No 2RDU Yes 3ZYS No
3QFT No 2RDW Yes 3KUC No
2VZ2 No 2PRH Yes 1GNP No
2QTZ No 2RDT Yes 1GNQ No
3O55 No 3HR4 No 1GNR No
2UXX No 3KVJ No 1KAO No
2BK3 No 2NZL Yes 3CF6 No
3NKS No 2FPY Yes 3KUB No
3AHQ No 1QZU Yes 1FB1 No
3AHR No 3KVK No 3NC1 No
3QFC No 3KVM No 3NBY No
3QE2 No 2WKP Yes 3NBZ No
3QFB No 1HE4 Yes 3NCO No
3QFA No 2WV8 Yes 3Q7Q No
2WBI No 3QFC Yes 3Q72 No
2BYB No 3QE2 Yes 3Q7P No
3QFR No 3QFR Yes 1FBX No
2VRM No 3G0U Yes 2Q3F No
2VRL No 1D3H Yes 2CLS No
1QR2 No 3F1Q Yes 2J1L No
1GOS No 3FJ6 Yes 2EKI No
2CKJ No 3FJL Yes 2OCB No
2BXR No 3G0X Yes 3GFT No
2BXS No 2PRL Yes 2G6B No
3NHF No 2PRM Yes 3LLU No
3NHJ No 2W0U Yes 1KHE No
3NHK No 2Q9U Yes 1KHB No
3NHL No 2BOM Yes 1GUA No
3NHP No 1P4M No 2GMV No
3NHR No 3HY8 Yes 1WQ1 No
3NHS No 3KVL Yes 1TBG No
3NHU No 3FJO Yes 1AM4 No
3NHW No 3U2O Yes 2BC9 No
3NHY No 1Q9S No 1ZW6 No
3ZYX No 2WKQ Yes 2A5D No
1UMK No 2WKR Yes 2EW1 No
2H94 No 2FPT Yes 1A2B No
2VIG No 2FPV Yes 2FG5 No
2JIF No 2FPY Yes 3T5G No
2J3N No 2FQI Yes 1LF0 No
3PO7 No 1M51 No
1ZX1 No 1NHX No
1OJA No 1XTS No
2AAQ No 3EA5 No
2UXW No 1KHF No
3DJG No 1KHG No
3DK4 No 1QRA No
3DK9 No 3RAP No
2QR2 No 2GIL No
2F5Z No 2RAP No
2IW5 No 2B8W No
3DK8 No 2B92 No
3DJJ No 2D4H No
2Z5X No 2G3Y No
2Z5Y No 3CBQ No
3GOU No 1RRP No
3F1Q No 1DOA No
3FJ6 No 3P32 No
3FJL No 1K5D No
3G0X No 1K5G No
3LF5 No 3TW4 No
3H8Q No 2J5X No
3DU8 No 2DPX No
1T9G Yes 2GJS No
1S1Q No 1X3S No
2ZZC No 2GAO No
2ZZO No 2HT6 No
2ZZB No 1RA7 No
1SIR No 2OHF No
1OJD No 3T5I No
1OJ9 No 2A5F No
Table 6:  When the algorithm was tested with the nodes as C2, C6, O2 andC5a and an error margin of 1.0
angstroms the dimensions of the tetrahedral structure became to specific and could not pick up a lot of
proteins that actually had FMN bound to it. A low error margin increased the rate of false negatives.
Screening unannotated structures of PDB
After the algorithm was trained a pipeline script was prepared for the steps above so that files
from PDB that are unannotated could be quickly processed to see if the tertrahedral motif was
present in them. These files were found by searching PDB for structures with an unknown
function.
If the proteins did not survive the steps then a blank output was generated and hence that
protein eliminated.
These are the proteins that survived the screening from 1372 proteins (5.17%) in PDB.
1.1ovq – Hypothetical protein in E.Coli that could be a nuclease resolving Holliday junction
intermediates in genetic recombination  by being redox active coordination complexes and
hence may have FMN binding motif.
2. 1pc2 - Human mitochondrial protein Fis1 having a high likelihood of having a FMN binding
motif
3. 1q53 - Hypothetical protein At3g17210 from A. thaliana with unknown function.
4. 1rfl – E.Coli MnmE protein which is equivalent to proteins in eukaryotes crucial for
mitochondrial respiration. Its homologues have FMN binding motifs.
5. 1tr4 - Human gankyrin which is known to complex with coenzyme FMN.
6. 1u3n – A prokaryotic superoxide dismutase paralog lacking two Cu ligands. Its homologues
are known to have FMN and NADPH ligand binding motifs.
7. 1wix - Mouse Hook homolog1. Homologues have a FMN binding site.
8.1xpn- PA1324 protein in Pseudomonas aeruginosa having unknown function
9.1ydu - At5g01610 protein in Arabidopsis thaliana having unknown function.
10.1yyc - putative late embryogenesis abundant protein with unknown function
11. 2asy - E. coli protein YdhR which likely belongs to a recently identified group of mono
oxygenase proteins that have a FMN binding site.
12.2do8 - UPF0301 protein HD_1794 of Haemophilus ducreyi having an unknown function
13.2e63 - KIAA1787 protein of Drosophila having an unknown function
14.2ec4- FAF1 in humans that probably plays a role as an apoptotic signaling regulator and may
have a
FMN binding site
15.2fyw - Hypothetical protein in Streptococcus pneumonia having unknown function
16. 1iyg – Hypothetical protein in mouse having unknown function
17.1j7h – Hypothetical protein HI0719 having unknown function
18. 1nxi - Hypothetical protein VC0424 from Vibrio cholera that is thought to behave like a
ferrodoxin. A FMN binding site is very likely.
19. 1sgo - Protein C14orf129 gene product in humans having unknown function
20. 2g0i - Hypothetical protein SMU 848 in Streptococcus mutans with unknown function.
21. 2fne - Multiple PDZ domain protein in humans having unknown function.
22.2dcq - Putative protein At4g01050 having unknown function.
23.2dcp - Hypothetical protein in A. thaliana having unknown function
24. 2daw – RWD domain containing protein 2 in humans that is thought to enhance the
sumoylation of a number of proteins. A FMN binding site is very likely.
25. 2dax - Protein C21orf6 in humans having unknown function
26.2cq9 - GLRX2 protein in humans having unknown function
27 2b3w - Hypothetical protein ybiA in E.coli having unknown function
28. 1dm5 – Annexin XII E105k mutant homohexamer in Hydra vulgaris having unknown function
29.1j31 - Hypothetical protein PH0642 in E.coli having unknown function
30. 1jal - YchF protein in Haemophilus influenza having unknown function
31.1jri - Sm like Archael Protein 1 in Methanothermobacter therautotrophicus having unknown
function
32.1kq4 - Hypothetical protein in Thermotoga maritime having unknown function
33. 1lj7 - Monomer hemoglobin component III in Glycera dibranchiate participating in oxygen
storage/ transport. Likely to have a FMN binding motif.
34.1lql - osmotical inducible protein C like family in Mycoplasma pneumonia having unknown
function
35. 1m98 – Orange carotenoid protein in Arthospira maxima having unknown function
36.1nf2 – Hypothetical protein in Thermotoga maritime having unknown function
37. 1nkq - Hypothetical protein in yeast having unknown function
38 1nmo - Hypothetical protein in ybgI having unknown function
39. 1nmp - Hypothetical protein in ybgI having unknown function
40. 1npy – Hypothetical protein in Haemophilus influenzae having unknown function
41. 1nr9 - Protein YCGM in E. coli with unknown function
42. 1nx8 - Carbapenem synthase of pectobacterium carotovorum having unknown function
43. 1nye – Osmotically inducible protein in E.coli having unknown function
44. 1o8c – Putative quinine oxidoreductase YHDH in E.coli. Very likely to have a FMN binding
motif
45. 1oq1 - Protein yesU in Bacillus subtilis having unknown function
46. 1oy1 – Putative sigma cross reacting protein 27A having unknown function
47. 1pt5. – Hypothetical protein yfdW in E.coli having unknown function.
48. 1pt7 - Hypothetical protein yfdW in E.coli having unknown function.
49. 1pt8 - Hypothetical protein yfdW in E.coli having unknown function.
50. 1qvv - YDR533c protein in yeast having unknown function
51. 1qv9 – F420 dependent methylenetetrahydromethanopterin dehrdrogenase in
Methanopyrus kandleri. This behaves as an oxidoreductase and is very likely to have a FMN
binding site.
52. 1rtw. – Putative transcriptional activator in Pyrococcus furiosus DSM 3638 having unknown
function.
53. 1sg9 - hemK protein in Thermotoga maritima having unknown function
54. 1t0b - ThuA like protein in Geobacillus stearothermophilus having unknown function
55. 1t0t – APC35880 protein in Geobacillus stearothermophilus having unknown function
56. 1syr – thioredoxin of Plasmodium falcipurum that might act as an oxidoreductase and is
likely to have a FMN binding site.
57. 1t2b – P450cin in Citrobacter braakii having unknown function.
58. 1t5r – LukS-PV in Staphylococcus phage having unknown function
59. 1tel – Ribulose biphosphate carboxylase in Chlorobium tepidum that is likely to have a FMN
binding motif.
60. 1to0 - Hypothetical protein in Bacillus subtilis having unknown function
61. 1tt7 – YHFP protein in Bacillus subtilis having unknown function
62. 1twy– ABC transporter protein of Vibrio clolerae
63. 1u5w - Hypothetical protein in E.coli having unknown function
64. 1uc2 - Hypothetical protein in Pyrococcus horikoshii having unknown function
65. 1uf3 - Hypothetical protein in Thermus thermophilius having unknown function
66. 1v8p - Hypothetical protein in Pyrobaculum aerophilum having unknown function
67. 1v8o - Hypothetical protein in Pyrobaculum aerophilum having unknown function
68. 1vdh– Muconolactone isomerase like protein in Thermus thermophilus having unknown
function
69. 1vhc – Putative KHG/KDPG aldolase in Haemophilus influenza having unknown function
70. 1vkd – Predicted glycosidase in Thermotoga maritima that is likely to have a FMN binding site.
71. 1wpb – Hypothetical protein in E.coli having unknown function
DISCUSSIONOF RESULTS:
Choosing the four nodes of the tetrahedral motif as amino acid sidechains or backbones that
bind to C2,C6,C5a,O2 of FMN and having a error margin of 1.4 angstroms as discussed above
led to a false positive rate of 4% and a false negative rate of 2.27%. Taking this into
consideration of the 71 protein structures tested positive 68 might actually be true positives
while of the 1301 structures that were rejected about 30 could have been rejected when they
should have been picked up. However a lot of the structures tested were not from humans and
since the training was done with structures from humans more work needs to be done to see
how much the tetrahedral motif varies between different organisms. If the variation is large
then the algorithm would have to be separately trained for each species.
Of the structures that were currently identified a lot of them were unknown proteins with
unknown functions. However it is noteworthy to mention that the protein 1PC2 was picked up
as a positive match. Now this protein is a mitochondrial fission protein. Though the ligand
information is unknown normally mitochondrial fission proteins are known to have FMN
involved [18]. Similarly 1wix is a mouse Hook homolog. Some of its homologues have been
known to have FMN binding sites [19]. However in some cases the algorithm did not do well.
Like 1rtw was identified as a positive hit. However it is putative transcriptional activator in
Pyrococcus furiosus DSM 3638 and it is highly unlikely that there is a FMN binding site in it.
1m98 is an Orange carotenoid protein in Arthospira maxima and again it is highly unlikely that
it has a FMN binding site even though the algorithm says so.
However the highly unlikely candidates are proteins that are found in species that are very
diverse from humans and hence the algorithm is likely not trained suitably for a species that is
not close to humans.
Since the algorithm suggests some likely proteins that possibly have FMN binding sites the next
step would be to do wet lab experiments and see if the hypothesis is true. Strong candidates as
the ones discussed above can act as a starting ground for future wet lab experiments and help in
establishing the success of the algorithm. If the algorithm is found to have performed reasonably
well it can be a ground breaking tool in identifying ligand binding sites for a particular ligand.
Pharmacophore identification can then act as a tool for discovering novel molecules and drugs
designed keeping the pharmacophore in mind.
CONCLUSION:
The idea for this work came from the benefits that were presented before us from the DCRR
model for protein representation. DCRR allowed us to simplify the protein structure
information by reducing the overall number of data points by 70%. This was a step forward
in identifying the pharmacophores which has remained a daunting task for years now. Using
the DCRR a tetrahedral motif could be identified and that motif could be used to screen a
large number of proteins quickly and efficiently. The DCRR also identifies the hydrogen
bonding and Van der waals information in separate files and they are immensely useful to
train the consensus ligand binding site for the  pharmacophore identifier algorithm
The mathematical modeling of a ligand binding site can lead to new drug discoveries by
promoting a way to screen normal proteins for those binding sites and thus revolutionize
medicine. Using the algorithm developed and the pipeline script a molecule can be quickly
screened to determine if the motif is present in it. This work serves as a very useful addon to
the DCRR project and demonstrates the effectiveness of using DCRR to revolutionize the
field of bioinformatics
Challenges
This project was a very challenging one to me and gave me the opportunity to acquire
new skill sets and programming knowledge. One of the big problems were the
inconsistency of the PDB format which could sometimes throw the programs written for
the algorithm off and not give outputs even though an output was expected. Just for this
even if the output files were blank (meaning the protein was eliminated) I had to double
check to see if there was a fault in the input files given and modify the programs
accordingly. Several fortran programs had to be changed to recognize the new format
before processing the data. More standardization in PDB would avoid this slowdown. One
of the other challenges I faced was disk space and managing it efficiently to process several
large files quickly. I had to use some servers from various places in order to accommodate
this.
FUTUREDIRECTIONS
This work was the first of its kind to utilize the DCRR files to find useful information.
However a lot of the process had to be manually started off in various steps. If I had the
chance to work on this project more
I would automate the whole process using newer technologies like Java/J2ee. This would not
only speed
the whole thing up but it would ensure that the output we get is more authentic. Several
programs could be written to act as listeners and then check the format of the file and then
modify the programs accordingly, recompile and then proceed with the steps. A web based
interface could be designed where the user could input the required information and be
notified of an output once the process is done.
Several other species could be considered while preparing the training site especially ones
that are close to humans.
Also several other ligands like FAD, NAD etc could be considered and phramacophore
templates found using the same methods. A library could then be maintained and made
available to everyone for use in research.
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Appendix
Script 1:
# Arkanjan Banerjee Step1
# October 2011, RIT
#!/bin/bash
grep "ASN" prot.dcrr | grep "scc" > nodes_file
grep "LYS" prot.dcrr | grep "scc" >> nodes_file grep "ALA"
prot.dcrr | grep "scc" >> nodes_file
grep "GLN" prot.dcrr | grep "scc" >> nodes_file grep "TYR"
prot.dcrr | grep "scc" >> nodes_file grep "THR" prot.dcrr | grep
"scc" >> nodes_file grep "THR" prot.dcrr | grep "bbc" >>
nodes_file grep "GLY" prot.dcrr | grep "bbc" >> nodes_file
cp nodes_file filea; # creates the 'home' file cp
nodes_file fileb; # creates 'neighbor' file
./nrst_nghbr.x; # runs the nearest neighbor program mv fileo
dist_1
grep "ALA" dist_1 | grep "scc" >> Group1 grep
"GLN" dist_1 | grep "scc" >> Group1
grep "TYR" dist_1 | grep "scc" >> Group2 grep
"THR" dist_1 | grep "scc" >> Group2 grep "THR"
dist_1 | grep "bbc" >> Group3 grep "GLY" dist_1 |
grep "bbc" >> Group3 grep "ASN" dist_1 | grep "scc"
>> Group4
grep "LYS" dist_1 | grep "scc" >> Group4
exit
Script 2:
# Arkanjan Banerjee Step2
# October 2011, RIT
#!/bin/bash
./dist_e1e3.x;
./dist_e1e2.x;
./dist_e2e3.x;
./dist_Re1.x;
./dist_Re2.x;
./dist_Re3.x;
cat Rn1 > Prot_all.Re1 ; cat Rn2 >
Prot_all.Re2; cat Rn3 >
Prot_all.Re3;
awk '{print $0" Re1"}' Prot_all.Re1 > Prot_all.Re1.t; awk '{print $0"
Re2"}' Prot_all.Re2 > Prot_all.Re2.t; awk '{print $0" Re3"}' Prot_all.Re3 >
Prot_all.Re3.t;
cat Prot_all.Re?.t > Prot_R_e1e2e3;
sort +2 -3 Prot_R_e1e2e3 > R_e1e2e3.s;
cp R_e1e2e3.s filei; gfortran find_clstrs_3_nodes.f90; ./a.out; mv fileo
R_e1e2e3.clstrs; \rm filei fc.f90 a.out;
cp R_e1e2e3.clstrs filei; gfortran ft_3nodes_.f90; ./a.out; mv fileo
R_e1e2e3.trees; \rm filei a.out;
sort +7 -8 R_e1e2e3.trees > R_e1e2e3.trees.s;
grep ' Re1' R_e1e2e3.trees.s > R_e1e2e3.trees.branch_Re1; grep ' Re2'
R_e1e2e3.trees.s > R_e1e2e3.trees.branch_Re2; grep ' Re3' R_e1e2e3.trees.s >
R_e1e2e3.trees.branch_Re3;
cp R_e1e2e3.trees.branch_Re1 filea; cp R_e1e2e3.trees.branch_Re2 fileb; ./fen.x; mv fileo edgenode_e1e2; \rm
file[a,b];
cp R_e1e2e3.trees.branch_Re1 filea; cp R_e1e2e3.trees.branch_Re3 fileb; ./fen.x; mv fileo edgenode_e1e3; \rm
file[a,b];
cp R_e1e2e3.trees.branch_Re2 filea; cp R_e1e2e3.trees.branch_Re3 fileb; ./fen.x; mv fileo edgenode_e2e3; \rm
file[a,b];
exit
